US 9587029
Human antibodies to the glucagon receptor and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9587029 (Human antibodies to the glucagon receptor and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39541, A61K39/3955